High-Risk Merchant Accounts

LegitScript Now Certifies Telehealth Sites That Offer BPC-157 Under HHS Conditions

LegitScript's November 2 update lets telehealth sites offering BPC-157 and five other peptides earn certification if they meet HHS's 503A conditions, but blends, pens, 503B products and state bans such as Kentucky's still stand in the way.

E-commerce 4 Internet Marketers Editorial
Regulatory & Compliance

Google Ads Will Accept NABP Accreditation for Telemedicine Certification

Google said on November 4, 2026 that telemedicine advertisers accredited through NABP's Healthcare Merchant Accreditation Program will be able to apply for Google Ads certification in the US, Canada and the UK once a November policy update is published. As of November 13 the live policy still names only LegitScript.

E-commerce 4 Internet Marketers Editorial
FDA & Product Rules

FDA Warns RonanRx Over American-Made Claims for Compounded GLP-1s

FDA's October 30, 2026 warning letter to RonanRx says a video calling its compounded semaglutide and tirzepatide "American made" and "farm-to-table drugs" was misleading because FDA lists no U.S. maker of the active ingredients. It also cites implied FDA approval and RonanRx-branded labels.

E-commerce 4 Internet Marketers Editorial
FDA & Product Rules

HHS Lets Pharmacies Compound BPC-157 and Five Other Peptides but Leaves Research-Use Sellers Out

HHS's October 28, 2026 interim enforcement discretion policy lets 503A pharmacies and physicians compound BPC-157, TB-500, Epitalon, KPV, MOTS-c and Semax under ten conditions, without adding them to the bulks list. Research-use-only sellers are left out, and comments close November 13.

E-commerce 4 Internet Marketers Editorial
FTC & Consumer Protection

Hims and Hers Asks a Judge to Toss the FTC Pixel and Subscription Case

Hims & Hers Health filed an October 22, 2026 motion to dismiss all nine counts in the FTC, California and Utah lawsuit over ad pixels, customer lists and subscription billing, arguing its privacy policy disclosed advertiser sharing and its plans fall outside ROSCA.

E-commerce 4 Internet Marketers Editorial
Chargebacks & Fraud

GLP-1 Telehealth Sellers Face Patients Told to Check the Dispensing Pharmacy First

USA Today's October 21 guide sends GLP-1 patients to state pharmacy license lookups, PCAB or CCE accreditation checks, and FDA's compounding actions list. An analysis of what telehealth sellers can disclose about the dispensing pharmacy to build trust and limit disputes.

E-commerce 4 Internet Marketers Editorial
FDA & Product Rules

Mississippi Pharmacy Board Says a Certificate of Analysis Does Not Clear Research-Grade Peptides

The Mississippi Board of Pharmacy's October 2026 newsletter says a certificate of analysis alone does not satisfy the state's joint peptide statement, that human-use disclaimers do not prevent enforcement, and that out-of-state telehealth prescribers need a Mississippi license.

E-commerce 4 Internet Marketers Editorial
Payments

DEA Telemedicine Flexibilities Near Their December 31 End With the Final Rule Still at White House Review

DEA's final rule creating a special registration for telemedicine has been under OMB review since August 25, 2026, with a November target and no public text, while the temporary flexibilities that let practitioners prescribe Schedule II through V drugs to never-seen patients expire at the end of December 31.

E-commerce 4 Internet Marketers Editorial
High-Risk Merchant Accounts

Eli Lilly Presses Card Companies and Processors to Cut Off Retatrutide Sellers

Eli Lilly's six retatrutide lawsuits came with a call for card companies and processors to cut off sellers, and a CBS News investigation then found more than 80 businesses promoting the unapproved drug under LegitScript's seal, raising the bar for licensed telehealth and compounding merchants in underwriting.

E-commerce 4 Internet Marketers Editorial
Chargebacks & Fraud

Split Descriptors for Telehealth Consult Fees Versus Pharmacy Fulfillment

Telehealth brands that bill consults and pharmacy fulfillment on separate MIDs can reduce statement confusion and chargebacks when checkout copy, refunds, and descriptors stay aligned. FDA GLP-1 telehealth pressure makes clean money flows part of processor survival too.

E-commerce 4 Internet Marketers Editorial